Cover Image
市場調查報告書

臨床化驗服務市場

Clinical Laboratory Services Market

出版商 Kalorama Information 商品編碼 341698
出版日期 內容資訊 英文 185 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
臨床化驗服務市場 Clinical Laboratory Services Market
出版日期: 2017年03月10日 內容資訊: 英文 185 Pages
簡介

化驗服務是醫療系統中的重要構成部門在體外診斷檢驗的商業化中也擔負著重要角色。醫生診斷約80%為基於臨床試驗的結果,這些試驗有相當數量是由臨床化驗服務供應商進行。

本報告提供各種臨床化驗服務的市場以美國為中心的調查、臨床實驗室概要、各種檢驗種類與概要、實驗室的分類和各實驗室種類的主要趨勢、對產業的影響因素 (高齡化、法律規章、償付、保險的影響等)分析、主要加入企業簡介、美國及全球主要地區的市場成長預測等彙整資料。

摘要整理

產業概要

  • 臨床實驗室概要
  • 試驗與服務
  • 例行檢查
    • 血球計算
    • 膽固醇值檢驗
    • HIV檢驗
    • PAP檢驗
    • 妊娠檢驗
    • 藥物濫用檢測
    • 尿液檢查
  • 專門的檢驗
    • 內分泌系檢驗
    • 特殊檢驗
    • 遺傳基因檢驗
    • 免疫學的、分子細菌學的檢驗
    • 癌症檢驗
    • 血清學的檢驗
  • 美國的臨床實驗室產業結構
  • CLIA登記實驗室:各類型
  • 獨立型臨床實驗室
    • 美國的成長趨勢
  • 醫院為基礎的實驗室
    • 美國的醫院資料
    • 美國的醫院逗留日數統計
    • 美國的成長趨勢
  • 診療所實驗室
    • 美國的醫生數
    • 美國的成長趨勢
  • 看護設施、居家醫療
    • 美國的看護設施數
    • 美國的居家醫療相關設施
    • 美國的成長趨勢
  • 藥局為基礎的實驗室
    • 美國的成長趨勢
  • 人工透析診所
    • 美國的成長趨勢
  • 全球臨床實驗室結構
  • 全球醫院、急救醫院的資料

臨床實驗室產業課題和各種趨勢

  • 課題和各種趨勢:概要
  • 人口動態
    • 全球人口動態
    • 各地區人口:概要
  • 老年人口
    • 慢性疾病、症狀的發病率
    • 外科手術數量
  • 法律規章概要
  • 醫療費支付者與償付
    • 化驗服務的支付者的各種類型
    • 醫療費償付趨勢
    • 醫療改革
  • 對ESRD (腎臟疾病) 患者的保險支付
    • ESRD品質獎勵計劃
  • HIPPA
  • 民間保險經營者
  • 資訊技術新的發展

主要加入企業

  • 摘要
  • Bio-Reference Laboratories
    • 企業概要
    • 業績檢討
    • 主要的收購、聯盟、合作關係
    • 產品與服務
    • 成長策略
    • 所在地
  • Clarient, Inc. (A GE Healthcare Company)
    • 企業概要
    • 業績檢討
    • 主要的收購、聯盟、合作關係
    • 產品與服務
    • 所在地
  • DaVita Healthcare Partners, Inc.
    • 企業概要
    • 業績檢討
    • 主要的收購、聯盟、合作關係
    • 產品與服務
    • 成長策略
    • 所在地
  • Genomic Health, Inc.
    • 企業概要
    • 業績檢討
    • 主要的收購、聯盟、合作關係
    • 產品與服務
    • 成長策略
    • 所在地
  • Genoptix, Inc.
    • 企業概要
    • 產品與服務
    • 成長策略
    • 所在地
  • Laboratory Corporation of America
    • 企業概要
    • 業績檢討
    • 主要的收購、聯盟、合作關係
    • 產品與服務
    • 成長策略
    • 所在地
  • Myriad Genetics, Inc
    • 企業概要
    • 業績檢討
    • 主要的收購、聯盟、合作關係
    • 產品與服務
    • 成長策略
    • 所在地
  • Quest Diagnostics, Inc.
    • 企業概要
    • 業績檢討
    • 主要的收購、聯盟、合作關係
    • 產品與服務
    • 成長策略
    • 所在地
  • Spectra Laboratories: A Fresenius Company
    • 企業概要
    • 主要的收購、聯盟、合作關係
    • 產品與服務
    • 成長策略
    • 所在地
  • Sonic Healthcare Limited
    • 企業概要
    • 業績檢討
    • 主要的收購、聯盟、合作關係
    • 產品與服務
    • 成長策略
    • 所在地

市場趨勢、摘要

  • 全球市場概要
  • 服務市場:試驗各種類
    • 例行檢查
    • 專門的檢驗
  • 美國市場概要
  • 市場分析:各實驗室類型
    • 醫院為基礎的臨床實驗室
    • 獨立型實驗室
    • 診療所實驗室
  • 市場分析:各試驗類型
    • 例行檢查
    • 專門的檢驗
  • 美國的競爭分析
  • 國際市場概要
  • 國際市場和趨勢
    • 亞太地區
    • 歐洲、中東
    • 南美

主要企業的清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KLI15279153

Clinical laboratories are an essential part of the health industry. It is estimated that approximately 80% of physicians' diagnoses are a result of laboratory tests. In addition to diagnosing patients, reasons clinical lab testing may be performed include evaluating disease progression, monitoring drug treatment and conditions, and determining individual therapy, among others. Clinical Laboratory Services Market provides an overview of the clinical laboratory industry and the trends driving growth. Market data presented include the following:

  • Global Clinical Laboratory Market Analysis, 2010-2021
  • Leading Market Participants, Global Service Revenues, 2014, 2015 and 2016
  • Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2016
  • Estimated U.S. Laboratory Service Revenues for Leading Clinical Laboratory Providers, 2010 vs. 2016
  • Global Clinical Laboratory Revenue Share by General Test Segment, 2016 (%)
  • Global Clinical Laboratory Market Analysis by Test Segment (Routine vs. Specialty), 2010-2021
  • Global Clinical Laboratory Market Analysis: Routine Testing Market Trend, 2010-2021
  • Global Clinical Laboratory Market Analysis: Specialty Testing Market Trend, 2010-2021

Internationally, the clinical laboratory market is growing. Clinical Laboratory Services Market presents information as a global focused market report. Key regions discussed include Northern America; Europe, Middle East, and Africa (EMEA); Asia Pacific; and Latin America. Datasets provided include the following:

  • Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2016 (Northern America; Europe, Middle East, Africa; Asia Pacific; Latin America; Total)
  • Northern America Market Value by Country, 2016 (Canada, United States, Rest of Northern America)
  • U.S. Clinical Laboratory Market Analysis, 2010-2021
  • U.S. Clinical Laboratory Market Analysis by Laboratory Type, 2010-2021 (Hospital-based, Physician-office, Independent, Total)
  • Clinical Laboratory Market Share by Laboratory Type, 2021 (Independent, Hospital-based, Physician-office)
  • U.S. Clinical Laboratory Market Analysis: Testing Service Revenues by Type, 2016 (Routine Clinical Chemistry, Toxicology / Drug abuse, Tissue Pathology, Other Specialty)
  • Europe/Middle East and Africa Market Value by Country, 2016 (Germany, France, Italy, Spain, United Kingdom, Switzerland, Rest of EMEA, Total)
  • Asia Pacific Market Value by Country, 2016 (China, Japan, India, South Korea, Australia, Rest of Asia Pacific, Total)
  • Latin America Market Value by Country, 2016 (Brazil, Mexico, Rest of Latin America, Total)

There are several primary issues and trends affecting the clinical laboratory market. Demographics, disease prevalence, and increasing life expectancy will continue to fuel growth in the future. New developments will also positively influence growth. Some of these issues are discussed in this study.

Issues and trends explored in this study include demographics, growing incidence of disease, new developments, regulatory environment, laboratory regulation, reimbursement, payer types, and developments in personalized medicine.

The clinical laboratory market is highly competitive in terms of prices, locations, and services offered. Larger laboratories have advantages in the market due to the wide exposure, large number of locations, and greater financial positions. The report profiles companies that are the leaders in the industry, including:

  • Alere, Inc.
  • Bio-Reference Laboratories - OPKO
  • DaVita Healthcare Partners, Inc.
  • Genomic Health, Inc.
  • Laboratory Corporation of America
  • Myriad Genetics, Inc.
  • Neogenomics, Inc.
  • Quest Diagnostics, Inc.
  • Siemens Healthineers
  • Sonic Healthcare Limited
  • Spectra Laboratories: A Fresenius Company
  • Synlab International GMBH

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. For the purpose of this study, Kalorama Information conducted interviews with more than 50 key industry officials, consultants, healthcare providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

INDUSTRY AT A GLANCE

SCOPE AND METHODOLOGY

GLOBAL MARKET OVERVIEW

  • Table 1-1: Global Clinical Laboratory Market Analysis, 2010-2021 (in millions of dollars at the manufacturer's level)
  • Figure 1-1: Global Clinical Laboratory Market Analysis: 2010-2021

MARKET CONCLUSIONS

KEY ISSUES AND TRENDS AFFECTING THE MARKET

LEADING MARKET PARTICIPANTS

CHAPTER TWO: INDUSTRY OVERVIEW

CLINICAL LABORATORY DESCRIPTION

TESTING AND SERVICES

  • Routine Testing
  • Table 2-1: Laboratory Reference Parameters for Complete Blood Count (CBC)
  • Table 2-2: High Cholesterol Risk Categories (Desirable levels, Borderline high, High risk)
  • Table 2-3: Raised or At-Risk Total Cholesterol (> = 190 mg/dL), Age Standardized Estimates, 2008 data (Iceland, Germany, Denmark, United Kingdom, Ireland, Italy, France, Netherlands, Switzerland, United Arab Emirates, Singapore, Japan, Poland, Thailand, Australia, United States, Israel, Canada, Mexico, Russian Federation, Argentina, Brazil, Philippines, Republic of Korea, Turkey, Saudi Arabia, Venezuela, China, India)
  • Table 2-4: Number of Reported HIV Testing and Counseling Services by Country, 2014 (India, Ethiopia, Uganda, Kenya, Nigeria, Mozambique, South Africa, Rwanda, United Republic of Tanzania, Zambia, Mexico, Kazakhstan, Malawi, Viet Nam, Côte d'Ivoire, Democratic Republic of the Congo, Zimbabwe, Malaysia, Thailand, Haiti, Peru, Belarus, Indonesia, Burundi, Cuba)
  • Table 2-5: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2015 (Afghanistan, Argentina, Australia, Belgium, Brazil, Canada, China, Democratic People's Republic of Korea, Denmark, France, Germany, India, Indonesia, Iran [Islamic Republic of], Iraq, Israel, Italy, Japan, Mexico, Netherlands, New Zealand, Philippines, Poland, Republic of Korea, Russian Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom of Great Britain and Northern Ireland, United States of America, Venezuela [Bolivarian Republic of], Viet Nam)
  • Table 2-6: HCG Levels in Pregnant Women by Days Past Ovulation
  • Table 2-7: Substance Detection Periods by Test Method (Alcohol, Cocaine, Morphine, Phenobarbital, Methadone, PCP, LSD, Heroin, Methamphetamine; Urine, Blood, Hair)
  • Table 2-8: Screening and Brief Interventions for Substance Abuse by Select Country, 2008 Data (Afghanistan, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Greece, Hungary, Iceland, India, Indonesia, Iran [Islamic Republic of], Iraq, Ireland, Israel, Italy, Japan, Mexico, Netherlands, New Zealand, Norway, Pakistan, Philippines, Poland, Republic of Korea, Russian Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, Venezuela [Bolivarian Republic of])
  • Table 2-9: Normal Reference Levels in a Medical Urinalysis
  • Specialty Testing

GLOBAL CLINICAL LABORATORY STRUCTURE

  • Global Hospital/Acute Care Data
  • Table 2-10: Hospital Density per 100,000 Population by Country, 2013 (Afghanistan, Brazil, Canada, China, France, Finland, Germany, Iceland, Indonesia, Iraq, Israel, Italy, Japan, Korea [Republic of], Malaysia, Mexico, Netherlands, Pakistan, Philippines, Poland, Saudi Arabia, Singapore, South Africa, Thailand, Turkey, United Kingdom, United States)
  • Figure 2-1: Hospitals per 100,000 Population by Country, 2013 (Afghanistan, Brazil, Canada, China, France, Finland, Germany, Iceland, Indonesia, Iraq, Israel, Italy, Japan, Korea [Republic of], Malaysia, Mexico, Netherlands, Pakistan, Philippines, Poland, Saudi Arabia, Singapore, South Africa, Thailand, Turkey, United Kingdom, United States)
  • Global Access to Physicians
  • Table 2-11: Medical Doctors per 1,000 Population by Country, 2013 (Afghanistan, Argentina, Australia, Brazil, Canada, China, France, Germany, India, Ireland, Israel, Italy, Japan, Mexico, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States, Vietnam)
  • Figure 2-2: Medical Doctors per 1,000 Population by Country, 2013 (Afghanistan, Argentina, Australia, Brazil, Canada, China, France, Germany, India, Ireland, Israel, Italy, Japan, Mexico, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States, Vietnam)
  • Global Nursing Establishments and Assisted Living Facilities
  • Table 2-12: Estimated Nursing Service Establishments and Care Centers by Country (Canada, China, France, Germany, Japan, United Kingdom, United States)
  • Figure 2-3: Estimated Nursing Service Establishments and Care Centers by Country (Canada, China, France, Germany, Japan, United Kingdom, United States)
  • Global Dialysis Clinics
  • Figure 2-4: Worldwide Dialysis Centers (Number of Facilities), 2001-2014
  • U.S. CLINICAL LABORATORY INDUSTRY STRUCTURE
  • Figure 2-5: Growth in Clinical Laboratories, 1997-2016

CLIA Laboratory Registration, Laboratories by Type

  • Figure 2-6: U.S. CLIA Clinical Laboratory Registration by Primary Laboratory Type: 1/2017 (Physician Office, Skilled Nursing / Nursing Facility, Home Health Agency, Hospital, Pharmacy, Community Clinic, ESRD Clinic, Independent, Others)
  • Table 2-13: CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined), January 2017 (Ambulance, Ambulatory Surgery Center, Ancillary Test Site, Assisted Living Facility, Blood Bank, Community Clinic, Comprehensive Outpatient Rehab, End Stage Renal Disease Dialysis, Federally Qualified Health Center, Health Fair, Health Maintenance Organization, Home Health Agency, Hospice, Hospital, Independent, Industrial, Insurance, Intermediate Care Facility for Mentally Retarded, Mobile Laboratory, Pharmacy, Physician Office, Other Practitioner, Prison, Public Health Laboratory, Rural Health Clinic, School/Student Health Service, Skilled Nursing/Nursing Facility, Tissue Bank/Repository, Other, Total)
  • Figure 2-7: Change in CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined) June 2013, July 2015 and January 2017 (Ambulance, Ambulatory Surgery Center, Ancillary Test Site, Assisted Living Facility, Blood Banks, Community Clinic, Comprehensive Outpatient Rehab, End Stage Renal Disease Dialysis, Federally Qualified Health Center, Health Fair, Health Maintenance Organization, Home Health Agency, Hospice, Hospital, Independent, Industrial, Insurance, Intermediate Care - Mentally Retarded, Mobile Laboratory, Pharmacy, Physician Office, Other Practitioner, Prison, Public Health Laboratory, Rural Health Clinic, School/Student Health Service, Skilled Nursing, Tissue Bank/Repositories, Other)
  • Independent Clinical Laboratories
  • Table 2-14: Leading U.S. Independent Laboratory Groups, as of January 2017
  • Figure 2-8: Leading U.S. Independent Laboratory Groups, Distribution of Centers, as of January 2017
  • Figure 2-9: Growth in U.S. Independent Laboratory Facilities, mid-2011 through January 2017
  • Hospital-based Laboratories
  • Table 2-15: U.S. Hospital Types
  • Table 2-16: U.S. Registered Hospitals by Type, 2010 through 2015 (Community Hospitals, Federal Government Hospitals, Non-federal Psychiatric Hospitals, Non-federal Long-term Care Hospitals, Institutional Hospitals [includes prison hospitals, college infirmaries, etc.], Total U.S. Registered Hospitals)
  • Figure 2-10: Number of Hospitals in the U.S., 1975-2015
  • Table 2-17: Statistics for U.S. Hospitals, 2012-2015 (Total Staffed Beds, Total Admissions, Total Expenses)
  • Figure 2-11: U.S. Hospital Length of Stay, Average by Age Group, 2014
  • Growth in Hospital Clinical Laboratories
  • Figure 2-12: Growth in U.S. Hospital Laboratory Locations, mid-2011 through January 2017
  • Physician-office Laboratories
  • Figure 2-13: Number of Physician Offices, United States, 2000-2010, Estimated 2015
  • Growth in Clinical Laboratories in the Physician Office
  • Figure 2-14: Growth in U.S. Physician Office Laboratory Locations, mid-2011 through January 2017
  • Nursing Facility and Home Health
  • Figure 2-15: Number of Nursing Homes (United States), 2000-2014
  • Growth in Clinical Laboratories in the Nursing Facility and Home Health Segment
  • Figure 2-16: Growth in U.S. Nursing Facility/Home Health Laboratory Locations, mid-2011 through January 2017
  • Pharmacy-based Laboratories
  • Growth in Pharmacy-Based Clinical Laboratories
  • Figure 2-17: Growth in U.S. Pharmacy-Based Laboratories, mid-2011 through January 2017
  • Dialysis Clinics
  • Growth in U.S. Dialysis Clinics and Affiliated Laboratories
  • Figure 2-18: U.S. Dialysis Facilities (Number of Clinics), 1991-2014
  • Figure 2-19: U.S. Dialysis Patients at Year's End, 2009-2014
  • Figure 2-20: Growth in U.S. Dialysis Clinic-based Laboratories, mid-2011 through January 2017

NUMBER OF LABORATORY HEALTH WORKERS BY COUNTRY

  • Figure 2-21: Laboratory Health Workers by Country, 2010-2014 Average (United States, China, Brazil, Korea, Mexico, Canada)

CHAPTER THREE: ISSUES AND TRENDS IN THE CLINICAL LABORATORY INDUSTRY

ISSUES AND TRENDS OVERVIEW

DEMOGRAPHICS

  • Global Demographics
  • Table 3-1: The Global Population, 1980-2050
  • Figure 3-1: The Global Population, 1980-2050 (in millions)
  • Regional Population Overview
  • Table 3-2: World Population by Major Geographic Region, 2010 - 2050 (Asia Pacific, Europe, Northern America, Latin America, Rest of World, World)
  • Figure 3-2: World Population by Major Geographic Region, 2010-2050 (Asia Pacific, Europe, Northern America, Latin America, Rest of World)
  • Aging Populations
  • Table 3-3: Global Population Trends Age 65+, 2000-2050
  • Figure 3-3: Global Population Trends Age 65+, 2000-2050 (Millions)

INCIDENCE OF CHRONIC DISEASES AND CONDITIONS

  • Figure 3-4: Global Causes of Death, 2014 and 2015

SURGICAL PROCEDURE VOLUMES

  • Table 3-4: Global Surgical Procedure Volume Forecast by Region, 2015-2030*
  • (procedures in thousands) (Northern America, Europe, Asia Pacific, Latin America, Rest of World, Total) .. 69

REGULATORY OVERVIEW

  • Certificate of Waiver
  • Table 3-5: Selected CLIA Waived Laboratory Tests
  • Certificate of Provider-Performed Microscopy Procedures (PPMP)
  • Table 3-6: Provider-Performed Microscopy Procedures
  • Certificate of Compliance and Certificate of Accreditation
  • Figure 3-5: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), January 2017
  • Table 3-7: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), January 2017
  • States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
  • Table 3-8: CLIA Exempt States, Number of Laboratories, January 2017 (New York, Washington)

PAYERS AND REIMBURSEMENT

  • Laboratory Service Payer Types
  • Table 3-9: U.S. Clinical Laboratory Clients and Payers by Type (%) (Medicare and Medicaid, Private Patient, Commercial Insurance, Managed Care)
  • Figure 3-6: Clinical Laboratory Clients and Payers by Type (Medicare/Medicaid, Private, Commercial, Managed Care)
  • Trends in Medicare Reimbursement
  • Table 3-10: Medicare Reimbursement Trends, 2009 vs. 2013 vs. 2015 vs. 2016
  • Health Care Reform
  • Protecting Access to Medicare Act (PAMA) of 2014
  • Bundled Insurance Payments for ESRD Patients
  • Table 3-11: Laboratory Tests Subject to ESRD Consolidated Billing (CY 2017)
  • Table 3-12: Comparison between New Bundled and Composite Medicare Reimbursement Program (1983-2010 and 2011+)
  • Commercial Insurance Providers

NEW DEVELOPMENTS IN INFORMATION TECHNOLOGY

CHAPTER FOUR: LEADING MARKET PARTICIPANTS

SUMMARY

  • Figure 4-1: Leading Market Participants, Global Service Revenues, 2014, 2015 and 2016 ($millions)
  • U.S. COMPETITIVE ANALYSIS
  • Table 4-1: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2016
  • Figure 4-2: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2016
  • Figure 4-3: Estimated U.S. Laboratory Service Revenues for Leading Clinical Laboratory Providers, 2010 vs. 2016

ALERE, INC.

  • Company Overview
  • Table 4-2: Alere Corporate Details
  • Performance Review
  • Figure 4-4: Alere Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

BIO-REFERENCE LABORATORIES - OPKO

  • Company Overview
  • Table 4-3: Bio-Reference Laboratories Corporate Details
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

DAVITA HEALTHCARE PARTNERS, INC.

  • Company Overview
  • Table 4-4: DaVita Healthcare Corporate Details
  • Performance Review
  • Figure 4-5: DaVita Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

GENOMIC HEALTH, INC.

  • Company Overview
  • Table 4-5: Genomic Health Corporate Details
  • Performance Review
  • Figure 4-6: Genomic Health Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

LABORATORY CORPORATION OF AMERICA

  • Company Overview
  • Table 4-6: Laboratory Corporation of America Corporate Details
  • Performance Review
  • Figure 4-7: Laboratory Corporation of America Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

MYRIAD GENETICS, INC.

  • Company Overview
  • Table 4-7: Myriad Genetics Corporate Details
  • Performance Review
  • Figure 4-8: Myriad Genetics Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

NEOGENOMICS, INC.

  • Company Overview
  • Table 4-8: NeoGenomics, Inc. Corporate Details
  • Performance Review
  • Figure 4-9: NeoGenomics Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

QUEST DIAGNOSTICS, INC.

  • Company Overview
  • Table 4-9: Quest Diagnostics Corporate Details
  • Performance Review
  • Figure 4-10: Quest Diagnostics Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

SIEMENS HEALTHINEERS

  • Company Overview
  • Table 4-10: Siemens Healthineers Corporate Details
  • Performance Review
  • Figure 4-11: Siemens' Healthineers Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

SONIC HEALTHCARE LIMITED

  • Company Overview
  • Table 4-11: Sonic Healthcare Corporate Details
  • Performance Review
  • Figure 4-12: Sonic Healthcare Revenue Summary, 2010-2016 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

SPECTRA LABORATORIES: A FRESENIUS COMPANY

  • Company Overview
  • Table 4-12: Spectra Laboratories Corporate Details
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

SYNLAB INTERNATIONAL GMBH

  • Company Overview
  • Table 4-13: SYNLAB International Corporate Details
  • Performance Review
  • Table 4-14: SYNLAB International Business Combination Details
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

CHAPTER FIVE: MARKET TRENDS AND SUMMARY

GLOBAL MARKET OVERVIEW

  • Table 5-1: Global Clinical Laboratory Market Analysis, 2010-2021 (in millions of dollars at the manufacturer's level)
  • Figure 5-1: Global Clinical Laboratory Market Analysis: 2010-2021

SERVICE MARKETS BY TEST SEGMENT

  • Figure 5-2: Global Clinical Laboratory Revenue Share by General Test Segment, 2016 (%)
  • Table 5-2: Global Clinical Laboratory Market Analysis by Test Segment (Routine vs. Specialty), 2010-2021 (in millions of dollars at the manufacturers' level)
  • Routine Testing
  • Table 5-3: Most Common Performed Routine Tests by Order Request, 2016
  • Figure 5-3: Global Clinical Laboratory Market Analysis: Routine Testing Market Trend, 2010-2021
  • Specialty Testing
  • Table 5-4: Most Common Performed Specialty Tests by Order Request, 2016
  • Figure 5-4: Global Clinical Laboratory Market Analysis: Specialty Testing Market Trend, 2010-2021

CHAPTER SIX: REGIONAL MARKETS AND TRENDS

OVERVIEW

  • Table 6-1: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2016 (Northern America; Europe, Middle East, Africa; Asia Pacific; Latin America; Total)
  • Figure 6-1: Global Clinical Laboratory Market Analysis, Revenues by Region, 2016 (Northern America; Europe, Middle East, Africa; Asia Pacific; Latin America)

NORTHERN AMERICAN MARKET OVERVIEW

  • Table 6-2: Northern America Market Value by Country, 2016 (in millions of dollars at the manufacturers' level) (Canada, United States, Rest of Northern America)
  • U.S. Clinical Laboratory Market
  • Table 6-3: U.S. Clinical Laboratory Market Analysis, 2010-2021 (in millions of dollars at the manufacturer's level)
  • Figure 6-2: U.S. Clinical Laboratory Market Analysis: 2010-2021
  • Market Analysis by Laboratory Type
  • Table 6-4: U.S. Clinical Laboratory Market Analysis by Laboratory Type, 2010-2021 (in millions of dollars at the manufacturers' level) (Hospital-based, Physician-office, Independent, Total)
  • Figure 6-3: U.S. Clinical Laboratory Market Share by Laboratory Type, 2016 (Independent, Hospital-based, Physician-office)
  • Figure 6-4: U.S. Clinical Laboratory Market Share by Laboratory Type, 2021 (Independent, Hospital-based, Physician-office)
  • Market Analysis by Test Type
  • Figure 6-5: U.S. Clinical Laboratory Market Analysis: Testing Service Revenues by Type, 2016 (Routine Clinical Chemistry, Toxicology / Drug abuse, Tissue Pathology, Other Specialty)

EUROPE AND MIDDLE EAST MARKET OVERVIEW

  • Table 6-5: Europe/Middle East and Africa Market Value by Country, 2016 (in millions of dollars at the manufacturers' level) (Germany, France, Italy, Spain, United Kingdom, Switzerland, Rest of EMEA, Total)

ASIA PACIFIC MARKET OVERVIEW

  • Table 6-6: Asia Pacific Market Value by Country, 2016 (in millions of dollars at the manufacturers' level) (China, Japan, India, South Korea, Australia, Rest of Asia Pacific, Total)

LATIN AMERICA MARKET OVERVIEW

  • Table 6-7: Latin America Market Value by Country, 2016 (in millions of dollars at the manufacturers' level) (Brazil, Mexico, Rest of Latin America, Total)

APPENDIX: LIST OF MAJOR COMPANIES

Back to Top